INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 50 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,039,000 | -11.6% | 1,292,000 | -17.2% | 0.00% | 0.0% |
| Q2 2020 | $1,175,000 | +35.8% | 1,561,000 | +44.4% | 0.00% | 0.0% |
| Q1 2020 | $865,000 | -3.4% | 1,081,000 | +21.7% | 0.00% | 0.0% |
| Q4 2019 | $895,000 | -56.3% | 888,000 | -61.4% | 0.00% | 0.0% |
| Q2 2019 | $2,048,000 | +33.1% | 2,298,000 | +47.7% | 0.00% | 0.0% |
| Q1 2019 | $1,539,000 | -10.5% | 1,556,000 | -30.1% | 0.00% | 0.0% |
| Q3 2017 | $1,720,000 | +27.8% | 2,227,000 | +60.8% | 0.00% | 0.0% |
| Q2 2017 | $1,346,000 | +29.2% | 1,385,000 | +23.8% | 0.00% | 0.0% |
| Q1 2017 | $1,042,000 | +88.8% | 1,119,000 | +80.5% | 0.00% | – |
| Q4 2016 | $552,000 | -34.8% | 620,000 | -18.1% | 0.00% | -100.0% |
| Q3 2016 | $846,000 | – | 757,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 3,300,000 | $2,640,000 | 2.48% |
| SYMPHONY ASSET MANAGEMENT LLC | 14,000,000 | $11,200,000 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 36,000,000 | $28,879,000 | 1.14% |
| Opera Trading Capital | 5,500,000 | $4,344,000 | 0.89% |
| MACKAY SHIELDS LLC | 17,789,000 | $14,221,000 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,415,000 | $19,539,000 | 0.37% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 6,000,000 | $4,918,000 | 0.37% |
| OAKTREE CAPITAL MANAGEMENT LP | 28,415,000 | $22,732,000 | 0.36% |
| GLG Partners LP | 8,700,000 | $6,960,000 | 0.33% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 42,285,000 | $33,828,000 | 0.28% |